The influence of glucan polymer structure and solution conformation on binding to (1→3)-β-D-glucan receptors in a human monocyte-like cell line

Glycobiology

Volumn 10, Issue 4, 2000, Pages 339-346

  Mueller, Antje ^a   Raptis, John ^a   Rice, Peter J ^a   Kalbfleisch, John H ^a   Stout, Robert D ^a   Ensley, Harry E ^b   Browder, William ^a   Williams, David L ^a  

^a East Tennessee State University   (United States)

^b Tulane University   (United States)

Author keywords

Binding; Glucan; Macrophage; Polymer; Receptor

Indexed keywords

CELL RECEPTOR; DEXTRAN; GLUCAN; GLUCAN RECEPTOR; LAMINARAN; MANNAN; PHOSPHATE; POLYMER; SCHIZOPHYLLAN; SCLEROGLUCAN; SULFATE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOHYDRATE ANALYSIS; CELL LINE; CELL STRAIN U937; CHEMICAL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MACROPHAGE; MOLECULAR WEIGHT; MONOCYTE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RECEPTOR BINDING;

HORDEUM VULGARE SUBSP. VULGARE;

EID: 0034070194     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/10.4.339     Document Type: Article

References (41)

1. Adams, D.S., Pero, S.C., Petro, J.B., Nathans, R., Mackin, W.M. and Wakshull, E. (1997) PGG-Glucan activates NF-κB-like and NF-IL-6-like transcription factor complexes in a murine monocytic cell line. J. Leukocyte Biol., 62, 865-873.
2. Ainsworth, A.J. (1994) A β-glucan inhibitable zymosan receptor on channel catfish neutrophils. Vet. Immunol. Immunopathol., 41, 141-152.
3. Babineau, T.J., Hackford, A., Kenler, A., Bistrian, B., Forse, R.A., Fairchild, P.G., Heard, S., Keroack, M., Causha, P. and Benotti, P. (1994a) A Phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (pgg-glucan) in high-risk surgical patients. Arch. Surgery, 129, 1204-1210.
4. Babineau, T.J., Marcello, P., Swails, W., Kenler, A., Bistrian, B. and Forse, R.A. (1994b) Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients. Ann. Surg., 220, 601-609.
5. Battle, J., Ha, T., Li, C., Della Beffa, V., Rice, P., Kalbfleisch, J., Browder, W. and Williams, D. (1998) Ligand binding to the (1-→3)-β-D-glucan receptor stimulates NFκB activation, but not apoptosis in U937 cells. Biochem. Biophys. Res. Commun., 249, 499-504.
6. Browder, W., Williams, D., Pretus, H., Olivero, G., Enrichens, F., Mao, P. and Franchello, A. (1990) Beneficial effect of enhanced macrophage function in the trauma patient. Ann. Surg., 211, 605-613.
7. Cabib, E., Mol, P.C., Shaw, J.A. and Choi, W.J. (1993) Biosynthesis of cell wall and septum during yeast growth. Arch. Med. Res., 24, 301-303.
8. Chiba, N., Ohno, N., Terui, T., Adachi, Y. and Yadomae, T. (1996) Effect of highly branched (1->3)-β-D-glucan, OL-2, on zymosan-mediated hydrogen peroxide production by murine peritoneal macrophages. Pharmaceutical Pharmacol. Lett., 6, 12-15.
9. Duan, X., Ackerly, M., Vivier, E. and Anderson, P. (1994) Evidence for involvement of beta-glucan-binding cell surface lectins in human natural killer cell function. Cell Immunol., 157, 393-402.
10. Dushkin, M.I., Safina, A.F., Vereschagin, E.I. and Schwartz, Y.S. (1996) Carboxymethylated β-1,3-glucan inhibits the binding and degradation of acetylated low density lipoproteins in macrophages in vitro and modulates their plasma clearance in vivo. Cell Biochem. Funct., 16, 185-215.
11. Elorza, M.V., Garcia de la Cruz, F., San Juan, R., Marcilla, A., Rico, H., Mormeneo, S. and Sentandreu, R. (1993) Linkages between macromolecules in Candida albicans cell wall. Arch. Med. Res., 24, 305-310.
12. Ensley, H.E., Tobias, B., Pretus, H.A., McNamee, R.B., Jones, E.L., Browder, I.W. and Williams, D.L. (1994) NMR spectral analysis of a water-insoluble (1-3)-β-D-glucan isolated from Saccharomyces cerevisiae. Carbohydr. Res., 258, 307-311.
13. Fearon, D.T. and Locksley, R.M. (1996) The instructive role of innate immunity in the acquired immune response. Science, 272, 50-53.
14. Felippe, J., Silva, M., Maciel, F.M., Soares, A. and Mendes, N.F. (1993) Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan). Surg. Gynecol. Obstet., 177, 383-388.
15. Kapteyn, J.C., Montijn, R.C., Dijkgraaf, G.J.P., Van den Ende, H. and Klis, F.M. (1995) Covalent association of β-1, 3-glucan with β-1, 1-6 glucosylated mannoproteins in cell walls of Candida albicans. J. Bacteriol., 177, 3788-3792.
16. Kiho, T., Katsuragawa, M., Nagai, K. and Ukai, S. (1992) Structure and antitumor activity of a branched (1-3)-β-D-glucan from the alkaline extract of Amanita muscaria. Carbohydr. Res., 224, 237-243.
17. Kojima, T., Tabata, K., Itoh, W. and Yanaki, T. (1986) Molecular weight dependence of the antitumor activity of Schizophyllan. Argic. Biol. Chem., 50, 231-232.
18. Kulicke, W.-M., Lettau, A.I. and Thielking, H. (1997) Correlation between immunological activity, molar mass and molecular structure of different (1-3)-β-D-glucans. Carbohydr. Res., 297, 135-143.
19. Kurachi, K., Ohno, N. and Yadomae, T. (1990) Preparation and antitumor activity of hydroxyethylated derivatives of 6-branched (1→3)-β-D-glucan, SSG, obtained from the culture filtrate of Sclerotinia sclerotiorum IFO 9395. Chem. Pharm. Bull. Tokyo, 38, 2527-2531.
20. Lowman, D., Ensley, H. and Williams, D. (1998) Identification of phosphate substitution sites by NMR spectroscopy in a water-soluble phosphorylated (1-3)-β-D-glucan. Carbohydr. Res., 306, 559-562.
21. Michalek, M., Melican, D., Brunke-Reese, D., Langevin, M., Lemerise, K., Galbraith, W., Patchen, M. and Mackin, W. (1998) Activation of rat macrophages by Betafectin PGG-glucan requires cross-linking of membrane receptors distinct from complement receptor three (CR3). J. Leukocyte Biol., 64, 337-344.
22. Miyazaki, T., Kohno, S., Mitsutake, K., Maesaki, S., Tanaka, K., Ishikawa, N. and Hara, K. (1995) Plasma (1→3)-β-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis and cryptococcosis. J. Clin. Microbiol., 33, 3115-3118.
23. Mueller, A., Pretus, H., McNamee, R., Jones, E., Browder, I. and Williams, D. (1995) Comparison of the carbohydrate biological response modifiers Krestin, schizophyllan and glucan phosphate by aqueous size exclusion chromatographty with in-line argon-ion multi-angle laser light scattering photometry and differential viscometry detectors. J. Chromatogr., 666, 283-290.
24. Mueller, A., Rice, P.J., Ensley, H.E., Coogan, P.S., Kalbfleisch, J.H., Kelley, J.L., Love, E.J., Portera, C.A., Ha, T., Browder, I.W. and Williams, D.L. (1996) Receptor binding and internalization of water-soluble (1→3)-β-D-glucan biologic response modifier in two monocyte/macrophage cell lines. J. Immunol., 156, 3418-3425.
25. Nemoto, J., Ohno, N., Saito, K., Adachi, Y. and Yadomae, T. (1993) Expression of interleukin 1 family mRNAs by a highly branched (1→3)-β-D-glucan, OL-2. Biol. Pharm. Bull., 16, 1046-1050.
26. Obayashi, T. (1997) (1→)-β-D-Glucanemia in deep mycosis. Mediat. Inflamm., 6, 271-273.
27. Obayashi, T., Yoshida, M., Tamura, H., Aketagawa, J., Tanaka, S. and Kawai, T. (1992) Determination of plasma (1-3)-β-D-glucan: a new diagnostic aid to deep mycosis. J. Med. Vet. Med., 30, 275-280.
28. Okamoto, K., Yamamoto, T., Nonaka, D., Shin, H., Okada, K., Hayashi, J. and Kashiwagi, S. (1998) Plasma (1→3)-β-D-glucan measurement and polymerase chain reaction on sputum as practical parameters in Pneumocystis carinii pneumonia. Intern. Med., 37, 618-621.
29. Pretus, H.A., Ensley, H.E., McNamee, R.B., Jones, E.L., Browder, I.W. and Williams, D.L. (1991) Isolation, physicochemical characterization and preclinical efficacy evaluation of soluble scleroglucan. J. Pharmacol. Exp. Ther., 257, 500-510.
30. Stahl, P.D. (1992) The mannose receptor and other macrophage lectins. Curr. Opinion Immunol., 4, 49-52.
31. Suzuki, I., Hashimoto, K. and Yadomae, T. (1988) The effects of a highly branched β-1,3-glucan. SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the growth of syngeneic tumors in mice. J. Pharmacobio-Dyn., 11, 527-532.
32. Tamura, H., Arimoto, Y., Tanaka, S., Yoshida, M., Obayashi, T. and Kawai, T. (1994) Automated kinetic assay for endotoxin and (1→3)-β-D-glucan in human blood [letter]. Clin. Chim. Acta, 226, 109-112.
33. Tamura, H., Tanaka, S., Ikeda, T., Obayashi, T. and Hashimoto, Y. (1997) Plasma (1→3)-β-d-glucan assay and immunohistochemical staining of (1→3)-β-D-glucan in the fungal cell walls using a novel horseshoe crab protein (T-GBP) that specifically binds to (1→3)-β-D-glucan. J. Clin. Lab. Anal., 11, 104-109.
34. Thornton, B.P., Vetvicka, V., Pitman, M., Goldman, R.C. and Ross, G.D. (1996) Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol., 156, 1235-1246.
35. Vereschagin, E.I., Van Lambalgen, A.A., Dushkin, M.I., Schwartz, Y.S., Polyakov, L., Heemskerk, A., Huisman, E., Thijs, L.G. and Van den Bos, G.C. (1998) Soluble glucan protects against endotoxin shock in the rat: the role of the scavenger receptor. Shock, 9, 193-198.
36. Vetvicka, V., Thornton, B.P. and Ross, G.D. (1996) Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J. Clin. Invest., 98, 50-61.
37. Vetvicka, V., Thornton, B.P., Wieman, J. and Ross, G.D. (1997) Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3. J. Immunol., 159, 599-605.
38. Williams, D.L., McNamee, R.B., Jones, E.L., Pretus, H.A., Ensley, H.E., Browder, I.W. and Di Luzio, N.R. (1991a) A method for the solubilization of a (1-3)-β-D-glucan isolated from Saccharomyces cerevisiae. Carbohydr. Res., 219, 203-213.
39. Williams, D.L., Mueller, A. and Browder, W. (1996) Glucan-based macrophage stimulators: A review of their anti-infective potential. Clin. Immunother., 5, 392-399.
40. Williams, D.L., Pretus, H.A., McNamee, R.B., Jones, E.L., Ensley, H.E., Browder, I.W. and Di Luzio, N.R. (1991b) Development, physicochemical characterization and preclinical efficacy evaluation of a water soluble glucan sulfate derived from Saccharomyces cerevisiae. Immunopharmacology, 22, 139-156.
41. Zimmerman, J.W., Lindermuth, J., Fish, P.A., Palace, G.P., Stevenson, T.T. and DeMong, D.E. (1998) A novel carbohydrate-glycosphingolipid interaction between a β-(1-3)-glucan immunomodulator, PGG-glucan and lactosylceramide of human leukocytes. J. Biol. Chem., 273, 22014-22020.